Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

tozasertib lactate

The lactate salt of tozasertib, a synthetic, small-molecule Aurora kinase inhibitor with potential antitumor activity. Tozasertib binds to and inhibits Aurora kinases (AKs), thereby inducing apoptosis in tumor cells in which AKs are overexpressed. AKs, a family of serine-threonine kinases, are essential for mitotic progression, spindle formation, centrosome maturation, chromosomal segregation, and cytokinesis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Aurora kinase inhibitor MK-0457
Code name:MK-0457
VX-680
Chemical structure:N-[4-[[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2- yl]sulfanyl]phenyl]cyclopropanecarboxamide (2S)-2-hydroxypropanoate
propanoic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5- methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search